Transcriptome-wide RNA interaction profiling reveals physical and functional targets of hnRNP L in human T cells

Molecular and Cellular Biology

Volumn 34, Issue 1, 2014, Pages 71-83

  Shankarling, Ganesh ^a   Cole, Brian S ^a   Mallory, Michael J ^a   Lynch, Kristen W ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD45 ANTIGEN; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN L; T LYMPHOCYTE RECEPTOR; WNT PROTEIN;

ALTERNATIVE RNA SPLICING; ANIMAL CELL; ARTICLE; CD4+ T LYMPHOCYTE; EXON; HUMAN; HUMAN CELL; IN VITRO STUDY; LEUKEMIA CELL LINE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN RNA BINDING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA PROCESSING; SIGNAL TRANSDUCTION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

ALTERNATIVE SPLICING; BASE SEQUENCE; BINDING SITES; CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; EXONS; HETEROGENEOUS-NUCLEAR RIBONUCLEOPROTEIN L; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTEIN BINDING; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; RNA SPLICE SITES; T-LYMPHOCYTES; TRANSCRIPTOME;

EID: 84891387068     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.00740-13     Document Type: Article

References (58)

1. Nilsen TW, Graveley BR. 2010. Expansion of the eukaryotic proteome by alternative splicing. Nature 463:457-463. http://dx.doi.org/10.1038/nature08909.
2. Bomsztyk K, Denisenko O, Ostrowski J. 2004. hnRNP K: one protein multiple processes. Bioessays 26:629-638. http://dx.doi.org/10.1002/bies.20048.
3. Makeyev AV, Liebhaber SA. 2002. The poly(C)-binding proteins: a multiplicity of functions and a search for mechanisms. RNA 8:265-278. http://dx.doi.org/10.1017/S1355838202024627.
4. Martinez-Contreras R, Cloutier P, Shkreta L, Fisette J-F, Revil T, Chabot B. 2007. hnRNP proteins and splicing control. Adv. Exp. Med. Biol. 623:123-147. http://dx.doi.org/10.1007/978-0-387-77374-2_8.
5. Hung LH, Heiner M, Hui J, Schreiner S, Benes V, Bindereif A. 2008. Diverse roles of hnRNP L in mammalian mRNA processing: a combined microarray and RNAi analysis. RNA 14:284-296. http://dx.doi.org/10.1261/rna.725208.
6. Erkelenz S, Mueller WF, Evans MS, Busch A, Schoneweis K, Hertel KJ, Schaal H. 2013. Position-dependent splicing activation and repression by SR and hnRNP proteins rely on common mechanisms. RNA 19:96-102. http://dx.doi.org/10.1261/rna.037044.112.
7. Martinez NM, Lynch KW. 2013. Control of alternative splicing in immune responses: many regulators, many predictions, much still to learn. Immunol. Rev. 253:216-236. http://dx.doi.org/10.1111/imr.12047.
8. Ansel KM. 2013. RNA regulation of the immune system. Immunol. Rev. 253:5-11. http://dx.doi.org/10.1111/imr.12062.
9. Rothrock CR, House AE, Lynch KW. 2005. HnRNP L represses exon splicing via a regulated exonic splicing silencer. EMBO J. 24:2792-2802. http://dx.doi.org/10.1038/sj.emboj.7600745.
10. Topp JD, Jackson J, Melton AA, Lynch KW. 2008. A cell-based screen for splicing regulators identifies hnRNP LL as a distinct signal-induced repressor of CD45 variable exon 4.RNA14:2038-2049. http://dx.doi.org/10.1261/rna.1212008.
11. Tong A, Nguyen J, Lynch KW. 2005. Differential expression of CD45 isoforms is controlled by the combined activity of basal and inducible splicing-regulatory elements in each of the variable exons. J. Biol. Chem. 280:38297-38304. http://dx.doi.org/10.1074/jbc. M508123200.
12. Gaudreau MC, Heyd F, Bastien R, Wilhelm B, Moroy T. 2012. Alternative splicing controlled by heterogeneous nuclear ribonucleoprotein L regulates development, proliferation, and migration of thymic pre-T cells. J. Immunol. 188:5377-5388. http://dx.doi.org/10.4049/jimmunol.1103142.
13. Hui J, Stangl K, Lane WS, Bindereif A. 2003. HnRNP L stimulates splicing of the eNOS gene by binding to variable-length CA repeats. Nat. Struct. Biol. 10:33-37. http://dx.doi.org/10.1038/nsb875.
14. Hermiston ML, Xu Z, Majeti R, Weiss A. 2002. Reciprocal regulation of lymphocyte activation by tyrosine kinases and phosphatases. J. Clin. Invest. 109:9-14. http://dx.doi.org/10.1172/JCI14794.
15. Xu Z, Weiss A. 2002. Negative regulation of CD45 by differential homodimerization of the alternatively spliced isoforms. Nat. Immunol. 3:764-771. http://dx.doi.org/10.1038/ni822.
16. Majeti R, Bilwes AM, Noel JP, Hunter T, Weiss A. 1998. Dimerizationinduced inhibition of receptor protein tyrosine phosphatase function through an inhibitory wedge. Science 279:88-91. http://dx.doi.org/10.1126/science.279.5347.88.
17. Preussner M, Schreiner S, Hung LH, Porstner M, Jack HM, Benes V, Ratsch G, Bindereif A. 2012. HnRNP L and L-like cooperate in multipleexon regulation of CD45 alternative splicing. Nucleic Acids Res. 40:5666-5678. http://dx.doi.org/10.1093/nar/gks221.
18. Rothrock C, Cannon B, Hahm B, Lynch KW. 2003. A conserved signalresponsive sequence mediates activation-induced alternative splicing of CD45. Mol. Cell 12:1317-1324. http://dx.doi.org/10.1016/S1097-2765(03)00434-9.
19. Motta-Mena LB, Heyd F, Lynch KW. 2010. Context-dependent regulatory mechanism of the splicing factor hnRNP L. Mol. Cell 37:223-234. http://dx.doi.org/10.1016/j.molcel.2009.12.027.
20. Ule J. 2009. High-throughput sequencing methods to study neuronal RNA-protein interactions. Biochem. Soc. Trans. 37:1278-1280. http://dx.doi.org/10.1042/BST0371278.
21. Ule J, Jensen K, Mele A, Darnell RB. 2005. CLIP: a method for identifying protein-RNA interaction sites in living cells. Methods 37:376-386. http://dx.doi.org/10.1016/j.ymeth.2005.07.018.
22. Xue Y, Zhou Y, Wu T, Zhu T, Ji X, Kwon YS, Zhang C, Yeo G, Black DL, Sun H, Fu XD, Zhang Y. 2009. Genome-wide analysis of PTB-RNA interactions reveals a strategy used by the general splicing repressor to modulate exon inclusion or skipping. Mol. Cell 36:996-1006. http://dx.doi.org/10.1016/j.molcel.2009.12.003.
23. Crooks GE, Hon G, Chandonia JM, Brenner SE. 2004. WebLogo: a sequence logo generator. Genome Res. 14:1188-1190. http://dx.doi.org/10.1101/gr.849004.
24. Martinez NM, Pan Q, Cole BS, Yarosh CA, Babcock GA, Heyd F, Zhu W, Ajith S, Blencowe BJ, Lynch KW. 2012. Alternative splicing networks regulated by signaling in human T cells. RNA 18:1029-1040. http://dx.doi.org/10.1261/rna.032243.112.
25. Shin KJ, Wall EA, Zavzavadjian JR, Santat LA, Liu J, Hwang JI, Rebres R, Roach T, Seaman W, Simon MI, Fraser ID. 2006. A single lentiviral vector platform for microRNA-based conditional RNA interference and coordinated transgene expression. Proc. Natl. Acad. Sci. U. S. A. 103: 13759-13764. http://dx.doi.org/10.1073/pnas.0606179103.
26. Wu Z, Jia X, de la Cruz L, Su XC, Marzolf B, Troisch P, Zak D, Hamilton A, Whittle B, Yu D, Sheahan D, Bertram E, Aderem A, Otting G, Goodnow CC, Hoyne GF. 2008. Memory T cell RNA rearrangement programmed by heterogeneous nuclear ribonucleoprotein hnRNPLL. Immunity 29:863-875. http://dx.doi.org/10.1016/j.immuni.2008.11.004.
27. Melton AA, Jackson J, Wang J, Lynch KW. 2007. Combinatorial control of signal-induced exon repression by hnRNP L and PSF. Mol. Cell. Biol. 27:6972-6984. http://dx.doi.org/10.1128/MCB.00419-07.
28. Jafarifar F, Yao P, Eswarappa SM, Fox PL. 2011. Repression of VEGFA by CA-rich element-binding microRNAs is modulated by hnRNP L. EMBO J. 30:1324-1334. http://dx.doi.org/10.1038/emboj.2011.38.
29. Hui J, Hung LH, Heiner M, Schreiner S, Neumuller N, Reither G, Haas SA, Bindereif A. 2005. Intronic CA-repeat and CA-rich elements: a new class of regulators of mammalian alternative splicing. EMBO J. 24:1988-1998. http://dx.doi.org/10.1038/sj.emboj.7600677.
30. Oberdoerffer S, Moita LF, Neems D, Freitas RP, Hacohen N, Rao A. 2008. Regulation of CD45 alternative splicing by heterogeneous ribonucleoprotein, hnRNPLL. Science 321:686-691. http://dx.doi.org/10.1126/science.1157610.
31. Lynch KW, Weiss A. 2000. A model system for activation-induced alternative splicing of CD45 pre-mRNA in T cells implicates protein kinase C and Ras. Mol. Cell. Biol. 20:70-80. http://dx.doi.org/10.1128/MCB.20.1.70-80.2000.
32. Rossbach O, Hung LH, Schreiner S, Grishina I, Heiner M, Hui J, Bindereif A. 2009. Auto- and cross-regulation of the hnRNP L proteins by alternative splicing. Mol. Cell. Biol. 29:1442-1451. http://dx.doi.org/10.1128/MCB.01689-08.
33. Maillard I, Fang T, Pear WS. 2005. Regulation of lymphoid development, differentiation, and function by the Notch pathway. Annu. Rev. Immunol. 23:945-974. http://dx.doi.org/10.1146/annurev.immunol.23.021704.115747.
34. Weiss A. 1995. Molecular and genetic insights into the role of protein tyrosine kinases inTcell receptor signaling. Clin. Immunol. Immunopathol. 76:S158-S162. http://dx.doi.org/10.1016/S0090-1229(95)90054-3.
35. Go WY, Liu X, Roti MA, Liu F, Ho SN. 2004. NFAT5/TonEBP mutant mice define osmotic stress as a critical feature of the lymphoid microenvironment. Proc. Natl. Acad. Sci. U. S. A. 101:10673-10678. http://dx.doi.org/10.1073/pnas.0403139101.
36. Liu P, Keller JR, Ortiz M, Tessarollo L, Rachel RA, Nakamura T, Jenkins NA, Copeland NG. 2003. Bcl11a is essential for normal lymphoid development. Nat. Immunol. 4:525-532. http://dx.doi.org/10.1038/ni925.
37. Ikawa T, Kawamoto H, Goldrath AW, Murre C. 2006. E proteins and Notch signaling cooperate to promote T cell lineage specification and commitment. J. Exp. Med. 203:1329-1342. http://dx.doi.org/10.1084/jem.20060268.
38. Wan YY, Chi H, Xie M, Schneider MD, Flavell RA. 2006. The kinase TAK1 integrates antigen and cytokine receptor signaling for T cell development, survival and function. Nat. Immunol. 7:851-858. http://dx.doi.org/10.1038/ni1355.
39. Yamamoto-Furusho JK, Barnich N, Xavier R, Hisamatsu T, Podolsky DK. 2006. Centaurin 1 down-regulates nucleotide-binding oligomerization domains 1-and 2-dependent NF-kB activation. J. Biol. Chem. 281: 36060-36070. http://dx.doi.org/10.1074/jbc. M602383200.
40. Ou CY, Kim JH, Yang CK, Stallcup MR. 2009. Requirement of cell cycle and apoptosis regulator 1 for target gene activation by Wnt and betacatenin and for anchorage-independent growth of human colon carcinoma cells. J. Biol. Chem. 284:20629-20637. http://dx.doi.org/10.1074/jbc. M109.014332.
41. Huelga SC, Vu AQ, Arnold JD, Liang TY, Liu PP, Yan BY, Donohue JP, Shiue L, Hoon S, Brenner S, Ares M, Jr, Yeo GW. 2012. Integrative genome-wide analysis reveals cooperative regulation of alternative splicing by hnRNP proteins. Cell Rep. 1:167-178. http://dx.doi.org/10.1016/j.celrep.2012.02.001.
42. Lagier-Tourenne C, Polymenidou M, Hutt KR, Vu AQ, Baughn M, Huelga SC, Clutario KM, Ling SC, Liang TY, Mazur C, Wancewicz E, Kim AS, Watt A, Freier S, Hicks GG, Donohue JP, Shiue L, Bennett CF, Ravits J, Cleveland DW, Yeo GW. 2012. Divergent roles of ALS-linked proteins FUS/TLS and TDP-43 intersect in processing long pre-mRNAs. Nat. Neurosci. 15:1488-1497. http://dx.doi.org/10.1038/nn.3230.
43. Yeo G, Burge CB. 2004. Maximum entropy modeling of short sequence motifs with applications to RNA splicing signals. J. Comput. Biol. 11:377-394. http://dx.doi.org/10.1089/1066527041410418.
44. Dikic I, Schlessinger J. 1998. Identification of a new Pyk2 isoform implicated in chemokine and antigen receptor signaling. J. Biol. Chem. 273: 14301-14308. http://dx.doi.org/10.1074/jbc.273.23.14301.
45. Davidson D, Chow LM, Fournel M, Veillette A. 1992. Differential regulation of T cell antigen responsiveness by isoforms of the src-related tyrosine protein kinase p59fyn. J. Exp. Med. 175:1483-1492. http://dx.doi.org/10.1084/jem.175.6.1483.
46. Van Parijs L, Refaeli Y, Lord JD, Nelson BH, Abbas AK, Baltimore D. 1999. Uncoupling IL-2 signals that regulate T cell proliferation, survival, and Fas-mediated activation-induced cell death. Immunity 11:281-288. http://dx.doi.org/10.1016/S1074-7613(00)80103-X.
47. Yu Y, Wang J, Khaled W, Burke S, Li P, Chen X, Yang W, Jenkins NA, Copeland NG, Zhang S, Liu P. 2012. Bcl11a is essential for lymphoid development and negatively regulates p53. J. Exp. Med. 209:2467-2483. http://dx.doi.org/10.1084/jem.20121846.
48. Davidson D, Viallet J, Veillette A. 1994. Unique catalytic properties dictate the enhanced function of p59fynT, the hemopoietic cell-specific isoform of the Fyn tyrosine protein kinase, in T cells. Mol. Cell. Biol. 14:4554-4564.
49. Appleby MW, Gross JA, Cooke MP, Levin SD, Qian X, Perlmutter RM. 1992. Defective T cell receptor signaling in mice lacking the thymic isoform of p59fyn. Cell 70:751-763. http://dx.doi.org/10.1016/0092-8674(92)90309-Z.
50. Beinke S, Phee H, Clingan JM, Schlessinger J, Matloubian M, Weiss A. 2010. Proline-rich tyrosine kinase-2 is critical for CD8 T-cell short-lived effector fate. Proc. Natl. Acad. Sci. U. S. A. 107:16234-16239. http://dx.doi.org/10.1073/pnas.1011556107.
51. Miyazaki T, Takaoka A, Nogueira L, Dikic I, Fujii H, Tsujino S, Mitani Y, Maeda M, Schlessinger J, Taniguchi T. 1998. Pyk2 is a downstream mediator of the IL-2 receptor-coupled Jak signaling pathway. Genes Dev. 12:770-775. http://dx.doi.org/10.1101/gad.12.6.770.
52. Slattery C, Ryan MP, McMorrow T. 2008. E2A proteins: regulators of cell phenotype in normal physiology and disease. Int. J. Biochem. Cell Biol. 40:1431-1436. http://dx.doi.org/10.1016/j.biocel.2007.05.014.
53. Schlissel M, Voronova A, Baltimore D. 1991. Helix-loop-helix transcription factor E47 activates germ-line immunoglobulin heavy-chain gene transcription and rearrangement in a pre-T-cell line. Genes Dev. 5:1367-1376. http://dx.doi.org/10.1101/gad.5.8.1367.
54. Lynch KW, Weiss A. 2001. A CD45 polymorphism associated with multiple sclerosis disrupts an exonic splicing silencer. J. Biol. Chem. 276: 24341-24347. http://dx.doi.org/10.1074/jbc. M102175200.
55. Jacobsen M, Schweer D, Ziegler A, Gaber R, Schock S, Schwinzer R, Wonigeit K, Lindert RB, Kantarci O, Hemmer B. 2000. A point mutation in PTPRC is associated with the development of multiple sclerosis. Nat. Genet. 26:495-499. http://dx.doi.org/10.1038/82659.
56. Liu G, Razanau A, Hai Y, Yu J, Sohail M, Lobo VG, Chu J, Kung SK, Xie J. 2012. A conserved serine of heterogeneous nuclear ribonucleoprotein L (hnRNP L) mediates depolarization-regulated alternative splicing of potassium channels. J. Biol. Chem. 287:22709-22716. http://dx.doi.org/10.1074/jbc. M112.357343.
57. Goehe RW, Shultz JC, Murudkar C, Usanovic S, Lamour NF, Massey DH, Zhang L, Camidge DR, Shay JW, Minna JD, Chalfant CE. 2010. hnRNP L regulates the tumorigenic capacity of lung cancer xenografts in mice via caspase-9 pre-mRNA processing. J. Clin. Invest. 120:3923-3939. http://dx.doi.org/10.1172/JCI43552.
58. Chiou NT, Shankarling G, Lynch KW. 2013. hnRNP L and hnRNP A1 induce extended U1 snRNA interactions with an exon to repress spliceosome assembly. Mol. Cell 49:972-982. http://dx.doi.org/10.1016/j.molcel.2012.12.025.